Starts & Stops: Kerecis Launches Third-Degree Burn Trial Of Kerecis Omega3 Fish-Skin Treatment
Executive Summary
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from Nov. 26 through Dec. 2, including trial announcements from Kerecis, CardioFocus, Crevast Medical, MicroPort Scientific, Becton Dickinson, Aria CV, among others.